Jonathan Jay Mazelsky, Executive Chair of the Board and officer of IDEXX Laboratories Inc /DE, filed a Form 4 on November 18, 2026, disclosing a disposition of 700 shares of common stock on November 16, 2026.
Key Highlights
- Reporting person: Jonathan Jay Mazelsky, identified as Executive Chair of the Board and officer of IDEXX Laboratories Inc /DE (NASDAQ:IDXX).
- Transaction type: Code "G" disposition, indicating a gift, of 700 shares of common stock on November 16, 2026, at a price of $0.
- Remaining holdings: Following the transaction, Mazelsky directly beneficially owns 83,103.302 shares of common stock.
- No derivative activity: Table II of the filing contains no reported derivative securities transactions.
- Filing signed: The form was signed by Lily J. Lu as Attorney-in-Fact for Jonathan Jay Mazelsky on November 18, 2026.
IDEXX Laboratories Executive Chair Reports Gift Disposition of Common Stock
According to the Form 4 filed with the U.S. Securities and Exchange Commission on November 18, 2026, Jonathan Jay Mazelsky, who holds the roles of Director and Executive Chair of the Board at IDEXX Laboratories Inc /DE (NASDAQ:IDXX), reported a single transaction involving the company's common stock. The transaction date was November 16, 2026, and no deemed execution date was listed.
The filing discloses a disposition of 700 shares of IDEXX Laboratories common stock. The transaction code recorded is "G," which under SEC Form 4 instruction conventions corresponds to a gift. The price attributed to the disposition is $0, consistent with a gift transaction. The shares were held and disposed of in direct ownership form.
Following this reported transaction, Mazelsky's direct beneficial ownership in IDEXX Laboratories common stock stands at 83,103.302 shares, as stated in Table I of the filing. No indirect ownership positions or derivative securities are reported in the filing. The form was filed by one reporting person and was submitted by Lily J. Lu acting as Attorney-in-Fact for Mazelsky.
What Was Disclosed
The filing reports a gift disposition of 700 shares of IDEXX Laboratories common stock by Executive Chair Jonathan Jay Mazelsky on November 16, 2026, at a price of $0, leaving him with direct beneficial ownership of 83,103.302 shares.



Please wait processing your request...